Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer
Authors:
- 3 April 2014
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 18 (2) , 288-296
Abstract
Patients with advanced gastric cancer (GC) have an adverse prognosis even after curative resection. Development of novel diagnostic and therapeutic approaches for GC is urgently required. The expression and methylation status of DENN/MADD domain-containing protein 2D (DENND2D), a member of the membrane trafficking proteins, were evaluated in 12 GC cell lines and 112 pairs of surgical specimens. Subgroup analysis based on tumor differentiation, location, and morphology was also performed. Expression and distribution of DENND2D protein were determined by immunohistochemistry. The majority of GC cell lines (75 %) and tissues (79 %) showed reduced expression of DENND2D mRNA compared with noncancerous gastric tissues. GC tissues showed a significantly lower mean expression level of mRNA and a higher frequency of promoter hypermethylation of DENND2D than corresponding noncancerous tissues. No significant differences in DENND2D mRNA expression and methylation status were found between GC subtypes categorized by tumor differentiation, location, and morphology. The expression patterns of DENND2D protein were confirmed to be consistent with those of DENND2D mRNA. Downregulation of DENND2D mRNA in GC tissues was significantly associated with factors related to more advanced GC and subsequent adverse prognosis. Among 72 patients who underwent R0 resection, downregulation of DENND2D mRNA in GC tissues was an independent prognostic factor and associated with early recurrence. Our results suggested that DENND2D is a putative tumor suppressor gene regulated by promoter hypermethylation in GC. Downregulation of DENND2D can serve as a novel tumor biomarker to predict progression and early recurrence of all types of GC.Keywords
This publication has 43 references indexed in Scilit:
- Molecular Classification of Gastric Cancer: A New ParadigmClinical Cancer Research, 2011
- DENN Domain Proteins: Regulators of Rab GTPasesJournal of Biological Chemistry, 2011
- Family-wide characterization of the DENN domain Rab GDP-GTP exchange factorsJournal of Cell Biology, 2010
- The Connecdenn Family, Rab35 Guanine Nucleotide Exchange Factors Interfacing with the Clathrin MachineryJournal of Biological Chemistry, 2010
- Integrin-mediated function of Rab GTPases in cancer progressionMolecular Cancer, 2010
- Rab GTPases as coordinators of vesicle trafficNature Reviews Molecular Cell Biology, 2009
- Trends in incidence of oesophageal and stomach cancer subtypes in EuropeEuropean Journal of Gastroenterology & Hepatology, 2009
- Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense‐mediated mRNA decayGenes, Chromosomes and Cancer, 2008
- Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME‐4, a coated‐pit proteinThe EMBO Journal, 2008
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000